Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease narcolepsy
Symptom |cataplexy
Sentences 170
PubMedID- 21486708 Conclusions: the multimodal, dreamlike aspect of hallucinations in narcolepsy with cataplexy could transiently impair the patients' insight.
PubMedID- 23821583 Results: we found an average 64% increase in the number of histamine neurons in human narcolepsy with cataplexy, with no overlap between narcoleptics and controls.
PubMedID- 26251634 We report on two narcolepsy patients with multiple daily cataplexy episodes, one of whom had been effectively treated with ghb, but had to discontinue it for unrelated medical reasons.
PubMedID- 21532956 In addition, narcolepsy with cataplexy in our clinic population appeared to begin at a younger age than usually reported in other studies.
PubMedID- 22435405 The autoimmune sleep disorder narcolepsy with cataplexy is caused by a loss of hypocretin-producing neurons in the brain .
PubMedID- 20160349 Elisa analysis showed that sera from narcolepsy patients with cataplexy had higher trib2-specific antibody titers compared with either normal controls or patients with idiopathic hypersomnia, multiple sclerosis, or other inflammatory neurological disorders.
PubMedID- 24416019 Dko mice display the most profoundly disturbed sleep phenotype of all three models: narcolepsy with cataplexy (transient episodes of behavioral arrest) (kalogiannis et al., 2011).
PubMedID- 20810312 Methods: nineteen drug-naive narcolepsy patients with cataplexy (10 males, 9 females, and mean age 28.5 years) and 25 age- and sex-matched healthy controls were recruited.
PubMedID- 24363733 The drug is recommended in obsessive compulsive disorders (ocd), in cataplexy associated with narcolepsy, and in depression when sedation is required (5-7).
PubMedID- 20689589 narcolepsy with cataplexy is caused by a derangement of orexin (also known as hypocretin) signaling , .
PubMedID- 23526549 This article reviews the contribution of neuroimaging to the pathophysiology of narcolepsy with cataplexy, focusing on the most recent developments.
PubMedID- 21387813 Conclusions: neurophysiological procedures (mslt) and biological markers are necessary in the diagnosis of narcolepsy with cataplexy and hypersomnia without cataplexy.
PubMedID- 21697009 Background: narcolepsy with cataplexy (nc) is a disabling disorder characterized by excessive daytime sleepiness and abnormal rapid eye movement (rem) sleep manifestations, due to a deficient hypocretin/orexin neurotransmission.
PubMedID- 25534169 Pseudo-cataplexy, a form of "psychogenic" narcolepsy, "pseudo-parasomnia" and pnes can have a similar presentation.
PubMedID- 25969754 Consistently, disruption of the orexin system leads to the sleep disorder narcolepsy with cataplexy in humans as well as in animal models .
PubMedID- 19555382 Although a close association between human leucocyte antigen (hla) and human narcolepsy with cataplexy suggests an involvement of autoimmune mechanisms, this has not yet been proved.
PubMedID- 26227560 Following the mass vaccinations against pandemic influenza a/h1n1 virus in 2009, a sudden increase in juvenile onset narcolepsy with cataplexy (nc) was detected in several european countries where as03-adjuvanted pandemrix vaccine had been used.
PubMedID- 23643651 Background: to test if the hypocretin (orexin) neuropeptide precursor (hcrt) gene, hcrt, mutations are implicated in the development of narcolepsy with cataplexy deficiency in young children.
PubMedID- 23496005 The aim of this study was to describe the clinical and psg characteristics of narcolepsy with cataplexy and their genetic predisposition by using the retrospective patient database of the european narcolepsy network (eu-nn).
PubMedID- 24297759 Methods: we enrolled 181 consecutive patients (108 men, 73 women; mean age 37.6 +/- 16.6 years old; narcolepsy with cataplexy/narcolepsy without cataplexy = 131:50).

Page: 1 2 3 4